Anne Santerre Henriksen

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 12

Top Topics

Multidrug Resistant

Biofilm Formation

Community Acquired Pneumonia

Klebsiella Pneumoniae

Top Venues

Microbiology spectrum

JAC-antimicrobial resistance

The Journal of antimicrobial chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Anne Santerre Henriksen, Fabio Arena, Marie Attwood, Rafael Canton, Sören Gatermann, Thierry Naas, Ian Morrissey, Christopher M Longshaw, null null
In vitro activity of cefiderocol against European Enterobacterales, including isolates resistant to meropenem and recentβ-lactam/β-lactamase inhibitor combinations. Microbiology spectrum (2024)
Anne Santerre Henriksen, Katy Jeannot, Antonio Oliver, John D Perry, Mathias W Pletz, Stefania Stefani, Ian Morrissey, Christopher M Longshaw, null null
In vitro activity of cefiderocol against European Pseudomonas aeruginosa and Acinetobacter spp., including isolates resistant to meropenem and recent β-lactam/β-lactamase inhibitor combinations. Microbiology spectrum 12 (4) (2024)
Anne Santerre Henriksen, Fabio Arena, Marie Attwood, Rafael Canton, Sören Gatermann, Thierry Naas, Ian Morrissey, Christopher M Longshaw, null null
In vitro activity of cefiderocol against European Enterobacterales, including isolates resistant to meropenem and recentβ-lactam/β-lactamase inhibitor combinations. Microbiology spectrum (2024)
Anne Santerre Henriksen, Katy Jeannot, Antonio Oliver, John D Perry, Mathias W Pletz, Stefania Stefani, Ian Morrissey, Christopher M Longshaw, null null
In vitro activity of cefiderocol against European Pseudomonas aeruginosa and Acinetobacter spp., including isolates resistant to meropenem and recent β-lactam/β-lactamase inhibitor combinations. Microbiology spectrum 12 (4) (2024)
Anne Santerre Henriksen, Katy Jeannot, Antonio Oliver, John D Perry, Mathias W Pletz, Stefania Stefani, Ian Morrissey, Christopher M Longshaw, null null
In vitro activity of cefiderocol against European Pseudomonas aeruginosa and Acinetobacter spp., including isolates resistant to meropenem and recent β-lactam/β-lactamase inhibitor combinations. Microbiology spectrum 12 (4) (2024)
Anne Santerre Henriksen, Katy Jeannot, Antonio Oliver, John D Perry, Mathias W Pletz, Stefania Stefani, Ian Morrissey, Christopher M Longshaw, null null
In vitro activity of cefiderocol against European Pseudomonas aeruginosa and Acinetobacter spp., including isolates resistant to meropenem and recent β-lactam/β-lactamase inhibitor combinations. Microbiology spectrum (2024)
Anne Santerre Henriksen, Fabio Arena, Marie Attwood, Rafael Canton, Sören Gatermann, Thierry Naas, Ian Morrissey, Christopher M Longshaw, null null
In vitro activity of cefiderocol against European Enterobacterales, including isolates resistant to meropenem and recentβ-lactam/β-lactamase inhibitor combinations. Microbiology spectrum (2024)
Christopher M Longshaw, Anne Santerre Henriksen, Dana Dressel, Michelle Malysa, Christian Silvestri, Miki Takemura, Yoshinori Yamano, Takamichi Baba, Christine M Slover
Heteroresistance to cefiderocol in carbapenem-resistant Acinetobacter baumannii in the CREDIBLE-CR study was not linked to clinical outcomes: a post hoc analysis. Microbiology spectrum (2023)
Rafael Cantón, Kamal A Hamed, Tatiana Wiktorowicz, Nowel Redder, Noelle Jemmely, Juan Quevedo, Anne Santerre Henriksen
In vitro activity of ceftobiprole and comparator antibiotics against contemporary European isolates (2016-19). JAC-antimicrobial resistance 4 (2) (2022)
Christopher M Longshaw, Anne Santerre Henriksen, Christine Slover, Yoshinori Yamano, J Andreas Karas
Comment on: Bacteraemia with an MBL-producing Klebsiella pneumoniae: treatment and the potential role of cefiderocol heteroresistance. The Journal of antimicrobial chemotherapy 77 (10) (2022)
Thierry Naas, Gerard Lina, Anne Santerre Henriksen, Christopher Longshaw, Francois Jehl
Erratum to: In vitro activity of cefiderocol and comparators against isolates of Gram-negative pathogens from a range of infection sources: SIDERO-WT-2014-2018 studies in France. JAC-antimicrobial resistance 3 (3) (2021)
Thierry Naas, Gerard Lina, Anne Santerre Henriksen, Christopher Longshaw, Francois Jehl
In vitro activity of cefiderocol and comparators against isolates of Gram-negative pathogens from a range of infection sources: SIDERO-WT-2014-2018 studies in France. JAC-antimicrobial resistance 3 (2) (2021)